Treatment of POEMS Syndrome With Daratumumab
Condition(s):POEMS SyndromeLast Updated:November 13, 2023Completed
Hide Studies Not Open or Pending
Condition(s):POEMS SyndromeLast Updated:November 13, 2023Completed
Condition(s):POEMS SyndromeLast Updated:April 25, 2017Completed
Condition(s):POEMS SyndromeLast Updated:July 5, 2019Completed
Condition(s):POEMS SyndromeLast Updated:September 2, 2010Unknown status
Condition(s):POEMS SyndromeLast Updated:July 29, 2016Completed
Condition(s):Plasmacytoma; POEMS SyndromeLast Updated:November 7, 2023Active, not recruiting
Condition(s):POEMS Syndrome; Amyloidosis; Autoimmune Hemolytic Anemia; VasculitisLast Updated:March 3, 2022Recruiting
Condition(s):Plasma Cell DisordersLast Updated:February 13, 2024Recruiting
Condition(s):POEMS Syndrome; Hemostatic DisorderLast Updated:May 31, 2023Recruiting
Condition(s):Chronic Inflammatory Demyelinating Polyneuropathy (CIDP); Vasculitic Neuropathy; POEMS Syndrome; Multifocal Motor Neuropathy; Charcot-Marie-Tooth; hATTR Amyloidosis; Diabetic Polyneuropathy; Idiopathic Neuropathy; PolyneuropathiesLast Updated:November 18, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.